Participation of central kappa-opioid receptor in arrhythmogenesis

Yu B. Lishmanov, L. N. Maslov, D. S. Ugdyzhekova, G. N. Smagin

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The effect of kappa receptors agonists and antagonists was studied in the model of epinephrine induced arrhythmias. Kappa receptor agonists U-50,488 and [D-Ala2]-Dynorphin A (1-13) administered ICV potentiate the arrhythmogenic effect of epinephrine. The effect of U-50,488 was completely blocked by kappa receptor antagonist, nor-binaltorphine. Administration of N-cholinergic receptor inhibitor, hexamethonium, prevented pro-arrhythmic effects of U-50,488 and [D-Ala2]-Dynorphin A (1-13). The data support the hypothesis that central kappa opioid receptors play an important role in the arrhythmogenesis.

Original languageEnglish
JournalLife Sciences
Volume61
Issue number3
DOIs
Publication statusPublished - 13 Jun 1997

Fingerprint

kappa Opioid Receptor
Epinephrine
Hexamethonium
Cholinergic Receptors
Cardiac Arrhythmias
dynorphin (1-13)

Keywords

  • Dynorphin
  • Epinephrine arrhythmias
  • Hexamethonium
  • Nor-binaltorphine
  • U-50,488

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Participation of central kappa-opioid receptor in arrhythmogenesis. / Lishmanov, Yu B.; Maslov, L. N.; Ugdyzhekova, D. S.; Smagin, G. N.

In: Life Sciences, Vol. 61, No. 3, 13.06.1997.

Research output: Contribution to journalArticle

Lishmanov, Yu B. ; Maslov, L. N. ; Ugdyzhekova, D. S. ; Smagin, G. N. / Participation of central kappa-opioid receptor in arrhythmogenesis. In: Life Sciences. 1997 ; Vol. 61, No. 3.
@article{a2086dd82a094fa68f23296e0cca2229,
title = "Participation of central kappa-opioid receptor in arrhythmogenesis",
abstract = "The effect of kappa receptors agonists and antagonists was studied in the model of epinephrine induced arrhythmias. Kappa receptor agonists U-50,488 and [D-Ala2]-Dynorphin A (1-13) administered ICV potentiate the arrhythmogenic effect of epinephrine. The effect of U-50,488 was completely blocked by kappa receptor antagonist, nor-binaltorphine. Administration of N-cholinergic receptor inhibitor, hexamethonium, prevented pro-arrhythmic effects of U-50,488 and [D-Ala2]-Dynorphin A (1-13). The data support the hypothesis that central kappa opioid receptors play an important role in the arrhythmogenesis.",
keywords = "Dynorphin, Epinephrine arrhythmias, Hexamethonium, Nor-binaltorphine, U-50,488",
author = "Lishmanov, {Yu B.} and Maslov, {L. N.} and Ugdyzhekova, {D. S.} and Smagin, {G. N.}",
year = "1997",
month = "6",
day = "13",
doi = "10.1016/S0024-3205(97)00391-3",
language = "English",
volume = "61",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Participation of central kappa-opioid receptor in arrhythmogenesis

AU - Lishmanov, Yu B.

AU - Maslov, L. N.

AU - Ugdyzhekova, D. S.

AU - Smagin, G. N.

PY - 1997/6/13

Y1 - 1997/6/13

N2 - The effect of kappa receptors agonists and antagonists was studied in the model of epinephrine induced arrhythmias. Kappa receptor agonists U-50,488 and [D-Ala2]-Dynorphin A (1-13) administered ICV potentiate the arrhythmogenic effect of epinephrine. The effect of U-50,488 was completely blocked by kappa receptor antagonist, nor-binaltorphine. Administration of N-cholinergic receptor inhibitor, hexamethonium, prevented pro-arrhythmic effects of U-50,488 and [D-Ala2]-Dynorphin A (1-13). The data support the hypothesis that central kappa opioid receptors play an important role in the arrhythmogenesis.

AB - The effect of kappa receptors agonists and antagonists was studied in the model of epinephrine induced arrhythmias. Kappa receptor agonists U-50,488 and [D-Ala2]-Dynorphin A (1-13) administered ICV potentiate the arrhythmogenic effect of epinephrine. The effect of U-50,488 was completely blocked by kappa receptor antagonist, nor-binaltorphine. Administration of N-cholinergic receptor inhibitor, hexamethonium, prevented pro-arrhythmic effects of U-50,488 and [D-Ala2]-Dynorphin A (1-13). The data support the hypothesis that central kappa opioid receptors play an important role in the arrhythmogenesis.

KW - Dynorphin

KW - Epinephrine arrhythmias

KW - Hexamethonium

KW - Nor-binaltorphine

KW - U-50,488

UR - http://www.scopus.com/inward/record.url?scp=0342617708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0342617708&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(97)00391-3

DO - 10.1016/S0024-3205(97)00391-3

M3 - Article

VL - 61

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 3

ER -